 - Patients must have a diagnosis of AML 20 myeloid blasts in the peripheral blood or bone marrow or MDS with 10 myeloid blasts in the bone marrow. Patients with Acute Promyelocytic Leukemia APL must be refractory to all-trans retinoic acid ATRA and arsenic trioxide. 